BioCentury
ARTICLE | Company News

AltaRex, ViRexx Medical deal

December 20, 2004 8:00 AM UTC

Cancer and hepatitis B company VIR completed its acquisition of cancer company ALT. ALT shareholders received 0.5 VIR shares for each ALT share, valuing ALT at $28.4 million based on a VIR price of $1...